Expect to See More Buprenorphine for Chronic Pain

April 2023

You’ll see more interest in buprenorphine for chronic pain...as it gains steam in new VA guidelines.

These guidelines recommend buprenorphine over full opioid agonists (morphine, etc)...if NON-opioids aren’t enough.

Buprenorphine is a partial agonist at mu-opioid receptors...and an ANTagonist at other opioid receptors.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote